SA25 Burden of Administration: Belantamab Mafodotin (Belamaf) Combinations vs Isatuximab (Isa) + Carfilzomib (K) + Dexamethasone (d), Daratumumab (D) + K + d, and K + d in Relapsed/Refractory Multiple Myeloma (RRMM). - SAMYSHKIN, Yevgeniy; Purser, Molly; Dlotko, Ewa; Macleod, Paul; Breslin, Katie; Boytsov, Natalie; McNamara, Simon; Sapra, Sandhya; Suvannasankha, Attaya (Value in Health, 2025)